ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
Dow Jones
44.303,40
-0,99%
Euro vs US Dollar
1,03275
-0,04%
Bitcoin
96.409,37
-0,14%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE

  6. Xeris Biopharma Inc (0A8E) Börsenkurse

Xeris Biopharma Inc

Xeris Biopharma Inc (0A8E)

LSE
0,00
0,00
(0,00%)
Geschlossen 08 Februar 5:30PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
-
Gebot
0,00
Fragen
0,00
Volumen
422
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
-
Handelsende
0,00
Handelsbeginn
-
Letzte Trade
282
@
3.5691
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
138.125.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-7,88
Gewinn pro Aktie (EPS)
-0,45
Erlöse
163,91M
Nettogewinn
-62,26M

Über Xeris Biopharma Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.xerispharma.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Xeris Biopharma Inc is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker 0A8E. The last closing price for Xeris Biopharma was US$0,00. Over the last year, Xeris Biopharma shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Xeris Biopharma currently has 138.125.000 shares in issue. Xeris Biopharma has a price to earnings ratio (PE ratio) of -7.88.

0A8E Neueste Nachrichten

Weitere Nachrichten

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 07 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

07 Oktober 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 06 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

06 Oktober 2021
UK Regulatory

Lazard Asset Management Form 8.3 - Xeris Pharmaceuticals, Inc

Lazard Asset Management 06 October 2021 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS...

06 Oktober 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 Amend

J.P. Morgan Securities LLC 05 October 2021 Ap19 AMENDMENT FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY...

05 Oktober 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 05 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

05 Oktober 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 04 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

04 Oktober 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 01 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

01 Oktober 2021
UK Regulatory

Morgan Stanley Smith Barney LLC Form 8.3 - XERIS PHARMACEUTICALS INC

Morgan Stanley Smith Barney LLC 01 October 2021 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

01 Oktober 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 30 September 2021 Ap19 AMENDMENT FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY...

30 September 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 30 September 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

30 September 2021
UK Regulatory
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0A8E - Frequently Asked Questions (FAQ)

What is the current Xeris Biopharma share price?
The current share price of Xeris Biopharma is US$ 0,00
How many Xeris Biopharma shares are in issue?
Xeris Biopharma has 138.125.000 shares in issue
What is the 1 year trading range for Xeris Biopharma share price?
Xeris Biopharma has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Xeris Biopharma?
The price to earnings ratio of Xeris Biopharma is -7,88
What is the cash to sales ratio of Xeris Biopharma?
The cash to sales ratio of Xeris Biopharma is 2,99
What is the reporting currency for Xeris Biopharma?
Xeris Biopharma reports financial results in USD
What is the latest annual turnover for Xeris Biopharma?
The latest annual turnover of Xeris Biopharma is USD 163,91M
What is the latest annual profit for Xeris Biopharma?
The latest annual profit of Xeris Biopharma is USD -62,26M
What is the registered address of Xeris Biopharma?
The registered address for Xeris Biopharma is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Xeris Biopharma website address?
The website address for Xeris Biopharma is www.xerispharma.com
Which industry sector does Xeris Biopharma operate in?
Xeris Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ASTAscent Resources Plc
1,90p
(100,00%)
591,55k
NTQEnteq Technologies Plc
2,85p
(58,33%)
17,97M
THRUThruvision Group Plc
3,25p
(30,00%)
307,66k
IMMImmupharma Plc
4,98p
(27,69%)
14,75M
GEXGeorgina Energy Plc
6,375p
(24,39%)
5,16M
BELLBelluscura Plc
1,875p
(-71,15%)
13,68M
APQApq Global Limited
2,00p
(-69,23%)
60,87k
IOMIomart Group Plc
45,40p
(-23,57%)
1,76M
SYMESupply@me Capital Plc
0,002p
(-20,00%)
736,23M
PRMProteome Sciences Plc
3,50p
(-17,45%)
50,06k
SYMESupply@me Capital Plc
0,002p
(-20,00%)
736,23M
ORCPOracle Power Plc
0,017p
(-14,14%)
523,64M
CPAICapai Plc
0,0475p
(7,95%)
355,25M
NTVONativo Resources Plc
0,0017p
(0,00%)
347,62M
MSMNMosman Oil And Gas Limited
0,04p
(2,56%)
263,67M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

LSE
0A8E
Xeris Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten